Low energy, weight gain and brain fog: what's worth testing
The symptoms most often dismissed, and which markers give you a real answer.
Regulation, research and clinical guidance all shift faster in this field than most patients realize. We track it here, in plain language, including the parts that complicate our own position.
In November 2025 the FDA announced it is asking manufacturers to remove the broad “black box” warning from menopausal hormone therapy labels, citing updated evidence on benefits and risks. Talk with a clinician about whether HRT fits your health history.
Read →In 2025 the FDA required class-wide labeling changes for testosterone products reflecting the TRAVERSE trial, which did not find increased major cardiovascular events, while keeping warnings about blood pressure increases. Monitoring with bloodwork remains important.
Read →The FDA determined in February 2025 that the semaglutide (Wegovy/Ozempic) shortage is resolved, which affects how compounded versions may be made. Medical weight loss should be guided by a licensed clinician.
Read →The SELECT trial (NEJM, 2023) found semaglutide reduced major cardiovascular events by about 20% in adults with overweight or obesity and existing heart disease, without diabetes.
Read →Plain explanations written by our medical team. No pitch attached, no email gate. If you read all of it and decide you don’t need us, that’s a good outcome.
What each marker measures, and why “in range” and “optimal” are different questions.
Membership stacking, cheap intake with expensive panels, cycle packages, the free front door.
The symptoms most often dismissed, and which markers give you a real answer.
The least understood and most under-treated part of women's hormone health.
Hematocrit, estradiol, PSA and lipids. Why ongoing labs separate treatment from guesswork.
What's established, what's still being studied, and where regulation currently sits.
One of the most common questions we get, and what the research says.
The cortisol relationship, what's real, and what you can act on.
Why testosterone suppresses sperm production, and what the options are if fertility matters to you.
The equation, the reasoning behind it, and why direct assays are less reliable.
And if you’d rather start with your own numbers, the panel is $249 including the provider review.